Targeting EPHA2 with Kinase Inhibitors in Colorectal Cancer
ChemMedChem · 2023-12 · 18 (23)
DOI: 10.1002/cmdc.202300420 ↗Kurz gefasst
Fachartikel in der Zeitschrift ChemMedChem, online erschienen am 05.10.2023. Verfasst von Alix Tröster und 6 weiteren Autor:innen. Beteiligte Einrichtung: Center for Biomolecular Magnetic Resonance, Institute for Organic Chemistry and Chemical Biology, Johann Wolfgang Goethe University, Max-von-Laue-Str…. Hauptthemen laut MEDLINE: Receptor, EphA2, Colorectal Neoplasms. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Intramural NIH HHS, Horizon 2020 Framework Programme.
Abstract (Originalsprache)
The ephrin type‐A 2 receptor tyrosine kinase (EPHA2) is involved in the development and progression of various cancer types, including colorectal cancer (CRC). There is also evidence that EPHA2 plays a key role in the development of resistance to the endothelial growth factor receptor (EGFR) monoclonal antibody Cetuximab used clinically in CRC. Despite the promising pharmacological potential of EPHA2, only a handful of specific inhibitors are currently available. In this concept paper, general strategies for EPHA2 inhibition with molecules of low molecular weight (small molecules) are described. Furthermore, available examples of inhibiting EPHA2 in CRC using small molecules are summarized, highlighting the potential of this approach.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Biomolecular Magnetic Resonance, Institute for Organic Chemistry and Chemical Biology, Johann Wolfgang Goethe University, Max-von-Laue-Straße 7, 60438, Frankfurt am Main, Germany.
- Laboratory of Cellular Oncology, Center for Cancer Research (CCR), National Cancer Institute (NCI), 37 Convent Drive, NIH Bethesda Campus Building 37, Room 4124, Bethesda, MD, 20892, USA.
ORCID-Profile: Konstantin S Mineev, Sridhar Sreeramulu, Michael DiPrima, Giovanna Tosato, Harald Schwalbe
Förderung
- Intramural NIH HHS
- Horizon 2020 Framework Programme
Zitieren
APA
Tröster, A., Jores, N., Mineev, K. S., Sreeramulu, S., DiPrima, M., Tosato, G., & Schwalbe, H. (2023). Targeting EPHA2 with Kinase Inhibitors in Colorectal Cancer. ChemMedChem, 18(23). https://doi.org/10.1002/cmdc.202300420
Vancouver
Tröster A, Jores N, Mineev KS, Sreeramulu S, DiPrima M, Tosato G, et al. Targeting EPHA2 with Kinase Inhibitors in Colorectal Cancer. ChemMedChem. 2023;18(23). doi:10.1002/cmdc.202300420
BibTeX
@article{Trster2023,
author = {Tröster, Alix and Jores, Nathalie and Mineev, Konstantin S and Sreeramulu, Sridhar and DiPrima, Michael and Tosato, Giovanna and Schwalbe, Harald},
title = {Targeting EPHA2 with Kinase Inhibitors in Colorectal Cancer},
journal = {ChemMedChem},
year = {2023},
volume = {18},
number = {23},
doi = {10.1002/cmdc.202300420}
}
EUVIMED